JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

CareDx Inc

Geschlossen

BrancheGesundheitswesen

14.29 -2.66

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

14.24

Max

15.15

Schlüsselkennzahlen

By Trading Economics

Einkommen

1.8M

-8.6M

Verkäufe

2M

87M

KGV

Branchendurchschnitt

13.819

37.003

Gewinnspanne

-9.885

Angestellte

644

EBITDA

9.3M

-4M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+22.7% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

4. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

71M

772M

Vorheriger Eröffnungskurs

16.95

Vorheriger Schlusskurs

14.29

Nachrichtenstimmung

By Acuity

76%

24%

348 / 373 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Neutral Evidence

CareDx Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Okt. 2025, 23:28 UTC

Heiße Aktien

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

29. Okt. 2025, 23:07 UTC

Ergebnisse

Prudential PLC 3Q New Business Profit Up 13%

30. Okt. 2025, 00:00 UTC

Ergebnisse

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

30. Okt. 2025, 00:00 UTC

Ergebnisse

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

30. Okt. 2025, 00:00 UTC

Ergebnisse

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

29. Okt. 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

29. Okt. 2025, 23:40 UTC

Ergebnisse

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

29. Okt. 2025, 23:38 UTC

Market Talk

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

29. Okt. 2025, 23:25 UTC

Ergebnisse

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

29. Okt. 2025, 22:51 UTC

Ergebnisse

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

29. Okt. 2025, 22:45 UTC

Ergebnisse

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

29. Okt. 2025, 22:41 UTC

Ergebnisse

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

29. Okt. 2025, 22:41 UTC

Ergebnisse

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

29. Okt. 2025, 22:09 UTC

Ergebnisse

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

29. Okt. 2025, 22:08 UTC

Market Talk
Ergebnisse

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

29. Okt. 2025, 21:58 UTC

Ergebnisse

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

29. Okt. 2025, 21:58 UTC

Ergebnisse

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

29. Okt. 2025, 21:57 UTC

Ergebnisse

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

29. Okt. 2025, 21:54 UTC

Ergebnisse

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

29. Okt. 2025, 21:46 UTC

Ergebnisse

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

29. Okt. 2025, 21:43 UTC

Ergebnisse

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

29. Okt. 2025, 21:43 UTC

Ergebnisse

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

29. Okt. 2025, 21:42 UTC

Ergebnisse

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

29. Okt. 2025, 21:42 UTC

Ergebnisse

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

29. Okt. 2025, 21:41 UTC

Ergebnisse

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

29. Okt. 2025, 21:41 UTC

Ergebnisse

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

29. Okt. 2025, 21:41 UTC

Ergebnisse

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

29. Okt. 2025, 21:41 UTC

Ergebnisse

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

29. Okt. 2025, 21:40 UTC

Ergebnisse

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

29. Okt. 2025, 21:39 UTC

Ergebnisse

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Peer-Vergleich

Kursveränderung

CareDx Inc Prognose

Kursziel

By TipRanks

22.7% Vorteil

12-Monats-Prognose

Durchschnitt 18 USD  22.7%

Hoch 22 USD

Tief 14 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für CareDx Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

2

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

14.77 / 18.49Unterstützung & Widerstand

Kurzfristig

Neutral Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

348 / 373 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat